Department Of Otolaryngology 1

1. Tactics of surgical treatment of recurrent glomus tumors of the skull base: A clinical case
2. Tactics of surgical treatment of recurrent glomus tumors of the skull base: A clinical case
3. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
4. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
5. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
6. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
7. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
8. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
9. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
10. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
11. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
12. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
13. Management of anaphylaxis due to COVID-19 vaccines in the elderly
14. Management of anaphylaxis due to COVID-19 vaccines in the elderly
15. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
16. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
17. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
18. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
19. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
20. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
21. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
22. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
23. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
24. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
25. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
26. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
27. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
28. Validity and Reliability of the French Olfactory Disorders Questionnaire-10
29. Global Burden of Orofacial Clefts and the World Surgical Workforce
30. Congenital Deficiency of Conventional Dendritic Cells Promotes the Development of Atopic Dermatitis-Like Inflammation
31. Reflux Symptom Index: Translation to the Kazakh Language and Validation
32. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021
33. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
34. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air^® real-world data
35. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
36. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
37. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
38. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
39. Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels
1